Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
'We are thrilled to enhance our product range while deepening our partnership with Ingredion,' said Aaron Lee, global senior vice president of Health & Nutrition for Univar Solutions. 'Through this agreement, we will expand access to pharmaceutical…
Swiss pharma company Galenica to cut up to 170 jobs at Bichsel
A consultation procedure is scheduled for mid-March. Galenica says it is examining “options for maintaining employment within the Group”. However, if redundancies are necessary, a redundancy programme will be implemented, including…
Eris Lifesciences, Natco Pharma ink pact on Semaglutide
Eris Lifesciences has forged a strategic partnership with Natco Pharma for commercialisation of semaglutide in India. Eris Lifesciences announcement, on Tuesday, comes in the backdrop of Natco Pharma recently receiving Central Drugs Standard…
Alembic Pharma gets U.S. FDA nod for generic antifungal drug
Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for antifungal drug Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically…
Making complex and innovative products at scale, the next frontier, say pharma chiefs
The Indian pharmaceutical industry has achieved scale in making generic medicines, but the next frontier is in making complex and innovative products and adopt new capabilities including AI, as they face geo-political headwinds, among other…
Stocks in focus: PSUs, IT and pharma stocks see key triggers
Tata group stocks will remain in focus as the board of Tata Sons, the holding company of Tata group companies, has deferred, on his recommendation, the decision to reappoint Tata Sons' Chairman N Chandrasekaran for a third term after some board…
BridgeBio Pharma Q4 Earnings Call Highlights
BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma NASDAQ: BBIO executives used the company's fourth-quarter 2025 earnings call to highlight accelerating commercial performance for its transthyretin amyloid…
Eris Lifesciences/Natco Pharma partner on semaglutide for India
Eris Lifesciences has announced a partnership with Natco Pharma for the commercialisation of semaglutide in India. Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Novo Nordisk's weightloss and diabetes drug Wegovy/ Ozempic…
Industry Group Rotation Since The Last Market High
Bespoke Investment Group 48.44K Followers As of 2/23, the S&P 500 was down about 2% since 1/28, while the mega-cap heavy Nasdaq 100 was down 5%. Within the broader large-cap Russell 1000, the average stock in the index is down just 0.3% since 1/28.
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells 45,481 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 45,481 shares of the company's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $35.31, for a…
BridgeBio Pharma (NASDAQ:BBIO) Posts Quarterly Earnings Results, Misses Expectations By $0.27 EPS
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.00) earnings per share for the quarter, missing analysts' consensus estimates of ($0.73) by ($0.27), FiscalAI reports. The…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of 'Moderate Buy' from Analysts
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have earned a consensus recommendation of 'Moderate Buy' from the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. One research…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0909 GMT – ConvaTec investors are likely to be reassured by the company's reiterated guidance and its…
KDventures's portfolio company SVF Vaccines announces that the intended merger with Novakand will not be carried out following negative decision from Nasdaq
STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be completed, following Nasdaq's rejection of an…
Trump tariffs: what 'powerful' trade weapons are at the US president's disposal?
Donald Trump did not carry through his threat to introduce 15% tariffs overnight. However, he did impose 10% tariffs on imports into the US on Tuesday, and the threatened 15% may be the least of his trade partners' worries. On Monday, the US…
Receive a Daily briefing on Pharma Industry News
Get Started